Novel Bruton's Tyrosine Kinase Inhibitors Currently in Development

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s33732
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

New and Emerging Bruton Tyrosine Kinase Inhibitors for Treating Mantle Cell Lymphoma – Where Do They Fit In?

Expert Review of Hematology
Hematology
2018English

Bruton Tyrosine Kinase Inhibitor ONO/GS-4059: From Bench to Bedside

Oncotarget
Oncology
2016English

Tyrosine Kinase Inhibitors in Lung Cancer

Hematology/Oncology Clinics of North America
OncologyHematology
2012English

Tyrosine Kinase Inhibitors for Diabetes

Science-Business eXchange
2008English

Tyrosine Kinase Inhibitors in Advanced Thyroid Cancer

Journal of the Siena Academy of Sciences
2012English

HGF Induces Novel EGFR Functions Involved in Resistance Formation to Tyrosine Kinase Inhibitors

Oncogene
Cancer ResearchGeneticsMolecular Biology
2012English

Bruton Tyrosine Kinase Inhibition Attenuates Liver Damage in a Mouse Warm Ischemia and Reperfusion Model

Transplantation
Transplantation
2017English

Personalized Therapy of Tyrosine Kinase Inhibitors

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
2013English

Small Molecule FLT3 Tyrosine Kinase Inhibitors

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy